CMV Viremia

12 registered clinical trials studyying CMV Viremia — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV I NCT07383649	The Methodist Hospital Research Institute	Phase 2
Recruiting	Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant NCT07079735	Columbia University	Phase 2 / Phase 3
Recruiting	Expansion of Virus-Specific Lymphocytes for Cell Therapy NCT06011486	Hospital Israelita Albert Einstein	Phase 1
Unknown	Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil NCT06263218	Hospital do Rim e Hipertensão	—
Recruiting	Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients NCT05432778	University Medical Centre Ljubljana	Phase 2
Completed	Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation NCT03443791	University of Alabama at Birmingham	N/A
Unknown	CMV Infection and Immune Intervention After Transplantation NCT04320303	Peking University People's Hospital	N/A
Terminated	Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells NCT03798301	University of Wisconsin, Madison	Phase 1
Unknown	The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human NCT04298502	Peking University People's Hospital	—
Completed	Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients NCT04018261	Banc de Sang i Teixits	Phase 1 / Phase 2
Completed	Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients NCT01329185	University of Minnesota	Phase 2
No Longer Available	Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Di NCT03010332	Atara Biotherapeutics	—